(Q35206981)

7 August 2017

1 reference

title

NSAIDs and Alzheimer's disease: how far to generalise from trials? (English)

1 reference

7 August 2017

0 references

John C S Breitner

1

1 reference

7 August 2017

1 September 2003

1 reference

7 August 2017

1 reference

7 August 2017

2

1 reference

7 August 2017

9

1 reference

7 August 2017

527

1 reference

Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial

7 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

Double placebo design in a prevention trial for Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2803%2900498-8

7 January 2021

10.1016/S1474-4422(03)00498-8

Identifiers

DOI

1 reference

7 August 2017

1 reference

PubMed ID

12941571